Catalan Life Sciences Database

-- Grifols acquires the remaining 56% share capital of the U.S. biopharmaceutical company for USD 80 million;-- GigaGen, dedicated to the discovery and development of recombinant biotherapeutic products, is working on the world's first recombinant polyclonal immunoglobulin;-- GigaGen received FDA... Read more ››

By: PR Newswire Association LLC. - 09 Mar 2021

Related companies: Grifols International, S.A

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 08 Mar 2021

Filing of the 2020 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report

By: GlobenewsWire - 04 Mar 2021

Quibim Receives FDA 510(k) Clearance for qp-Prostate New AI Solution for Prostate MRI Analysis

Groundbreaking AI tool brings analytical processes into one suite for radiologists, an industry first Read more ››

By: PR Newswire Association LLC. - 04 Mar 2021

Related companies: Quibim, S.L.

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

By: GlobenewsWire - 03 Mar 2021

Sanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members

By: GlobenewsWire - 03 Mar 2021

Highlight & Pivotal start Phase IIa melanoma trial

By: GlobenewsWire - 02 Mar 2021

Related companies: Highlight Therapeutics, S.L.

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

By: GlobenewsWire - 02 Mar 2021

Merck and GPHL Collaborate on Business Innovation and Development in the Greater Bay Area

By: PR Newswire Association LLC. - 02 Mar 2021

Syneos Health Announces Secondary Offering of Common Stock

By: GlobenewsWire - 01 Mar 2021

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 01 Mar 2021

Syneos Health Announces Pricing of Secondary Offering of Common Stock

By: GlobenewsWire - 01 Mar 2021

Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data

By: GlobenewsWire - 24 Feb 2021

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

By: GlobenewsWire - 24 Feb 2021

Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.

- Transaction furthers Terumo's efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care - Read more ››

By: PR Newswire Association LLC. - 24 Feb 2021

« 1 2 3 4 5 6 7 8 9 10 »

Looking for companies outside of Catalonia?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

May 2021
- European Health-tech Innovation Week
- 7th Annual Immuno-Oncology Innovation Forum
- Pharma-Biotech Product & Company Valuation Course

See Events »

Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
17 May 2021 (GlobenewsWire)

Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial
17 May 2021 (GlobenewsWire)

ORYZON to Present New Clinical Data and Corporate Updates at International Conferences in May and June
13 May 2021 (GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Catalonia?

Partners

Upcoming Life Sciences Events

Latest company news